Kestra Medical Technologies (KMTS) Gross Profit (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported Gross Profit for 3 consecutive years, with $15.7 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Gross Profit rose 105.45% year-over-year to $15.7 million; the TTM figure through Apr 2026 stood at $48.9 million (up 101.83% YoY), while the FY2026 annual figure was $48.9 million, up 101.83% from the prior year.
• Gross Profit climbed to $15.7 million in Q2 2026 per KMTS's latest filing, from $12.9 million in the prior quarter.
• Across five years, Gross Profit topped out at $15.7 million in Q2 2026 and bottomed at $880000.0 in Q1 2024.
• Historically, Gross Profit has averaged $7.5 million across 3 years, with a median of $7.1 million in 2025.
• On a YoY basis, Gross Profit climbed as much as 643.98% in 2025 and fell as far as 95.95% in 2025.
• Kestra Medical Technologies' Gross Profit stood at $5.8 million in 2024, then soared by 95.95% to $11.4 million in 2025, then soared by 37.27% to $15.7 million in 2026.
• Business Quant data shows KMTS's Gross Profit at $15.7 million in Q2 2026, $12.9 million in Q1 2026, and $11.4 million in Q4 2025.